| ERSGX | VISGX | ERSGX / VISGX | |
| Total Expense Ratio | 1.46 | 0.19 | 768% |
| Annual Report Gross Expense Ratio | 1.61 | 0.19 | 847% |
| Fund Existence | 16 years | 28 years | - |
| Gain YTD | -6.454 | 7.920 | -81% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 155M | 39.7B | 0% |
| Annual Yield % from dividends | 0.10 | 0.43 | 22% |
| Returns for 1 year | -13.68 | 3.97 | -344% |
| Returns for 3 years | 5.82 | 41.11 | 14% |
| Returns for 5 years | 5.73 | 27.42 | 21% |
| Returns for 10 years | -1.74 | 154.40 | -1% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SBHIX | 26.26 | 0.06 | +0.23% |
| Saratoga Health & Biotechnology I | |||
| SVBCX | 32.47 | 0.05 | +0.15% |
| JHancock Balanced C | |||
| SCUIX | 32.23 | 0.02 | +0.06% |
| Hartford Schroders US Small Cap Opps I | |||
| HRCUX | 72.37 | 0.03 | +0.04% |
| Carillon ClariVest Capital Apprec R6 | |||
| TMDIX | 19.24 | -0.02 | -0.10% |
| AMG TimesSquare Mid Cap Growth Z | |||